Indication
Rezdiffra is indicated in conjunction with diet and exercise for the treatment of adults with noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver fibrosis (fibrosis stages F2 to F3).
In other countries
The same active substances on other registers, the same brand first.
National listings
The national registers that list this EU medicine.
- Rezdiffra 100 MG Comprimidos Recubiertos con PeliculaSpain · 100 mgAuthorised
- Rezdiffra 60 MG Comprimidos Recubiertos con PeliculaSpain · 60 mgAuthorised
- Rezdiffra 80 MG Comprimidos Recubiertos con PeliculaSpain · 80 mgAuthorised
- Rezdiffra 100 mg filmomhulde tablettenNetherlandsAuthorised
- Rezdiffra 60 mg filmomhulde tabletten